On the eve of our Covid jag, we reviewed #Astrazeneca in February, speculating on a bottom of 6,776p, something the share price achieved and crucially, did not close a session below. Now, as we count down the hours until our 2nd injection, it’s worth taking another glance at this share, the price starting to show some interesting potentials. The bigger question the folks at Astrazeneca must be asking themselves is why they bothered?
From personal experience, we’ve no idea whether their vaccine works as the absence of infection in no way tells if there has been any exposure. Here in the sticks of Scotland, doubtless not but a few positive features of the experience are noteworthy. There were no side effects experienced, quite the converse. The writer has “enjoyed” chemotherapy twice in the last 2 years, thanks to incurable (non-fatal if treated) leukaemia. As a result, constant monitoring of the immune system kept showing a few tiny little problems which proved rather frightening. Following the initial Astrazeneca injection, there was a vivid improvement in the immune system, along with a (thankfully) sharp increase in the bodies platelet counts, meaning shaving no longer was a battle of thousands of cuts. In addition, quite apt at this time of year, white bedding no longer looking like it was doing a ‘Turin Shroud’ impersonation every morning. Such was the change in blood test results, the vampires at the hospital insisted on tests every fortnight since the Astrazeneca vaccine was administered, finally conceding grudgingly they didn’t want to see me for a few months.
However, Astrazeneca must sometimes with they’d never toyed with the idea of doing something good.
The company appear to be used as a political football by various governments, surely straining the patience of senior management quite unfairly. Most of them will be in their positions to “do business, not do politics” and any research behind headline scare stories has tended to reveal the biggest issues with their vaccine came from politicians bending in the wind as they attempt to portray themselves as competent, something the pandemic has tended illuminate was deadly clarity. The word ‘Politician’ should not be used in the same sentence as ‘Competent’, certainly as far as most world leaders are concerned.
However, last time around we’d a suspicion AZN’s price was about to experience some reversals but this time, we’re no longer comfortable this is the case. This week has seen the share price exceed the Blue downtrend since July 2020, giving considerable hope some gains may finally be coming. Near term, above 7,408 looks capable of triggering slight gains to an initial 7,662p. If bettered, our longer term secondary calculates at 8,150p. At such a level, our software demands the price actually close above 8,150p to give a “Game Changing” impression, dumping the share in territory where there’s a reasonable expectation a long term cycle target of 10,800p and a new all time high is possible.
For everything to go horribly wrong, the share price needs trade below 6,700p, risking commencing a drop cycle toward 5,439p.
|Time Issued||Market||Price At Issue||Short Entry||Fast Exit||Slow Exit||Stop||Long Entry||Fast Exit||Slow Exit||Stop||Prior|
30/03/2021 FTSE Closed at 6772 points. Change of 0.53%. Total value traded through LSE was: £ 5,037,784,451 a change of -0.62%
29/03/2021 FTSE Closed at 6736 points. Change of -0.06%. Total value traded through LSE was: £ 5,069,344,780 a change of -13.54%
26/03/2021 FTSE Closed at 6740 points. Change of 0.99%. Total value traded through LSE was: £ 5,863,243,404 a change of -5.15%
25/03/2021 FTSE Closed at 6674 points. Change of -0.57%. Total value traded through LSE was: £ 6,181,901,218 a change of 0.02%
24/03/2021 FTSE Closed at 6712 points. Change of 0.19%. Total value traded through LSE was: £ 6,180,734,714 a change of -2.58%
23/03/2021 FTSE Closed at 6699 points. Change of -0.4%. Total value traded through LSE was: £ 6,344,120,262 a change of 9.46%
22/03/2021 FTSE Closed at 6726 points. Change of 0.27%. Total value traded through LSE was: £ 5,795,599,482 a change of -59.88%
SUCCESS above means both FAST & SLOW targets were met. ‘CESS means just the FAST target met and probably the next time it is exceeded, movement to the SLOW target shall commence.
Our commentary is in two sections. Immediately below are today’s updated comments. If our commentary remains valid, the share can be found in the bottom section which has a RED heading. Hopefully, this will mean you no longer need to flip back through previous reports. HYPERLINKS DISABLED IN THIS VERSION
Please remember, all prices are mid-price (halfway between the Buy and Sell). When we refer to a price CLOSING above a specific level, we are viewing the point where we can regard a trend as changing. Otherwise, we are simply speculating on near term trading targets. Our website is www.trendsandtargets.com.
UPDATE. We often give an initial and a secondary price. If the initial is exceeded, we still expect it to fall back but the next time the initial is bettered, the price should continue to the secondary. The converse it true with price drops.
We can be contacted at firstname.lastname@example.org. Spam filters set to maximum so only legit emails get through…
Section One – Outlook Updated Today. Click here for Section Two – Outlook Remains Valid shares
Click Epic to jump to share: LSE:AV. Aviva** **LSE:BARC Barclays** **LSE:BLVN Bowleven** **LSE:FRES Fresnillo** **LSE:KAZ Kaz Minerals** **LSE:LLOY Lloyds Grp.** **LSE:POLY Polymetal** **LSE:STAN Standard Chartered** **LSE:ZOL Zoldav** **
Updated charts published on : Aviva, Barclays, Bowleven, Fresnillo, Kaz Minerals, Lloyds Grp., Polymetal, Standard Chartered, Zoldav,
LSE:AV.LSE:AV. Aviva. Close Mid-Price: 412.2 Percentage Change: + 2.72% Day High: 413.3 Day Low: 404
Target met. Further movement against Aviva ABOVE 413.3 should improve acc ……..
LSE:BARCLSE:BARC Barclays. Close Mid-Price: 189.14 Percentage Change: + 4.86% Day High: 190 Day Low: 182.4
Continued trades against BARC with a mid-price ABOVE 190 should improve t ……..
LSE:BLVN Bowleven Close Mid-Price: 4.75 Percentage Change: -17.39% Day High: 5.25 Day Low: 3.5
Target met. Continued weakness against BLVN taking the price below 3.5 ca ……..
LSE:FRES Fresnillo Close Mid-Price: 857.4 Percentage Change: -4.05% Day High: 898 Day Low: 853.4
If Fresnillo experiences continued weakness below 853.4, it will invariab ……..
LSE:KAZLSE:KAZ Kaz Minerals. Close Mid-Price: 866.4 Percentage Change: + 0.16% Day High: 868.6 Day Low: 864.2
In the event of Kaz Minerals enjoying further trades beyond 868.6, the sh ……..
LSE:LLOYLSE:LLOY Lloyds Grp.. Close Mid-Price: 43.1 Percentage Change: + 2.47% Day High: 43.16 Day Low: 42.45
Continued trades against LLOY with a mid-price ABOVE 43.16 should improve ……..
LSE:POLY Polymetal Close Mid-Price: 1389.5 Percentage Change: -1.73% Day High: 1429 Day Low: 1382
If Polymetal experiences continued weakness below 1382, it will invariabl ……..
LSE:STANLSE:STAN Standard Chartered. Close Mid-Price: 513.6 Percentage Change: + 2.31% Day High: 514 Day Low: 503.4
In the event of Standard Chartered enjoying further trades beyond 514, th ……..
LSE:ZOL Zoldav Close Mid-Price: 29 Percentage Change: -1.69% Day High: 29 Day Low: 28.5
If Zoldav experiences continued weakness below 28.5, it will invariably l ……..
*** End of “Updated Today” comments on shares.
This post has already been read 124 times!